The role of molecular biomarkers for predicting adjacent breast cancer of Atypical Ductal Hyperplasia diagnosed on core biopsy

Pinder SE , Ellis IO , The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)-current definitions and classification, Breast Cancer Res 5 (2003), 254-257.

Dupont WD , Parl FF , Hartmann WH , Brinton LA , Winfield AC , Worrell JA , et al., Breast cancer risk associated with proliferative breast disease and atypical hyperplasia, Cancer 71 (1993), 1258-1265.

Page DL , Dupont WD , Rogers LW , Landenberger M , Intraductal carcinoma of the breast: follow-up after biopsy only, Cancer 49 (1982), 751-758.

Polat AK , Kanbour-Shakir A , Andacoglu O , Polat AV , Johnson R , Bonaventura M , et al., Atypical Hyperplasia on Core Biopsy: Is Further Surgery Needed? Am J Med Sci 344 (2012), 28-3.

Darling ML , Smith DN , Lester SC , Kaelin C , Selland DL , Denison CM , et al., Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision, Am J Roentgenol 175 (2000), 1341-1346.

Degnim AC , King TA , Surgical management of high-risk breast lesions, Surg Clin North Am 93 (2013), 329-40.

Gam LH , Breast cancer and protein biomarkers, World J Exp Med 20 (2012), 86-89.

Rosen PP , Ductal hyperplasia, In: Rosen's Breast Pathology, 2nd ed. Philadelphia, PA: Lippincott Williams &Wilkins, 2001, pp. 201-228.

Schnitt SJ , Vincent-Salomon A , Columnar cell lesions of the breast, Adv Anat Pathol 10 (2003), 113-124.

American College of Radiology. Breast Imaging Reporting and Data System Atlas. 2003. Available at: http://www. acr.org/departments/stand_accred/birads/ contents.html. Accessed August 19, 2004.

Rassidakis GZ , Goy A , Medeiros LJ , Jiang Y , Thomaides A , Remache Y , Cabanillas F , et al., Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma, Clin Cancer Res 9 (2003), 2213-2220.

Andacoglu O , Kanbour-Shakir A , Teh YC , Bonaventura M , Ozbek U , Anello M , et al., Rationale of Excisional Biopsy After the Diagnosis of Benign Radial Scar on Core Biopsy: A Single Institutional Outcome Analysis, Am J Clin Oncol 36 (2013), 7-11.

Krishnamurthy S , Bevers T , Kuerer H , Yang WT , Multidisciplinary considerations in the management of high-risk breast lesions, AJR Am J Roentgenol 198 (2012), 132-140.

Eby PR , Ochsner JE , DeMartini WB , Allison KH , Peacock S , Lehman CD , Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge, AJR Am J Roentgenol 192 (2009), 229-234.

Houssami N , Ciatto S , Ellis I , Ambrogetti D , Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates, Cancer 109 (2007), 487-495.

Forgeard C , Benchaib M , Guerin N , Thiesse P , Mignotte H , Faure C , et al., Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients, Am J Surg 196 (2008), 339-345.

Khoury T , Chen X , Wang D , Kumar P , Qin M , Liu S , et al., Nomogram to predict the likelihood of upgrade of atypical ductal hyperplasia diagnosed on a core needle biopsy in mammographically detected lesions, Histopathology 67 (2015), 106-20.

Nguyen CV , Albarracin CT , Whitman GJ , Lopez A , Sneige N , Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: Considerations for surgical excision, Ann Surg Oncol 18 (2011), 752-761.

Deshaies I , Provencher L , Jacob S , Côté G , Robert J , Desbiens C , et al., Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy, Breast 20 (2011), 50-55.

Viacava P , Naccarato AG , Bevilacqua G , Different proliferative patterns characterize different preinvasive breast lesions, J Pathol 188 (1999), 245-251.

Xu R , Perle MA , Inghirami G , Chan W , Delgado Y , Feiner H , Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material, Mod Pathol 15 (2002), 116-124.

Lacunza E , Baudis M , Colussi AG , Segal-Eiras A , Croce MV , Abba MC , MUC1 oncogene amplification correlates with protein overexpression in invasive breast carcinoma cells, Cancer Genet Cytogenet 201 (2010), 102-110.

Liu T , Niu Y , Feng Y , Niu R , Yu Y , Lv A , et al., Methylation of CpG islands of p16 (INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast, Hum Pathol 39 (2008), 1637-46.

Radisky DC , Santisteban M , Berman HK , Gauthier ML , Frost MH , Reynolds CA , et al., p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res (Phila) 4 (2011), 1953-1960.

Fackler MJ , Rivers A , Teo WW , Mangat A , Taylor E , Zhang Z , et al., Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge, Clin Cancer Res 15 (2009), 3802-3811.

Umbricht CB , Evron E , Gabrielson E , Ferguson A , Marks J , Sukumar S , Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer, Oncogene 20 (2001), 3348-3353.

Zagouri F , Sergentanis TN , Nonni A , Papadimitriou CA , Michalopoulos NV , Domeyer P , et al., Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions, BMC Cancer 10 (2010), 353.

Polyak K , Is breast tumor progression really linear? Clin Cancer Res 15 (2008), 339-341.

Chai H , Brown RE , Field effect in cancer-an update, Ann Clin Lab Sci 39 (2009), 331-337.

Larson PS , de las Morenas A , Cupples LA , Huang K , Rosenberg CL , Genetically abnormal clones in histologically normal breast tissue, Am J Pathol 152 (1998), 1591-1598.

Kaneko M , Arihiro K , Takeshima Y , Fujii S , Inai K , Loss of heterozygosity and microsatellite instability in epithelial hyperplasia of the breast, J Exp Ther Oncol 2 (2002), 9-18.